CD8A and neoplasm: CoPoP liposomes have previously been used for in vivo screening to identify a short murine cancer CD8+ neoepitope termed Nes2LR fom the Renca tumor cell line [34] and to identify tumor-associated antigens with mutations that lead to improved functional immunogenicity.